We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00486213
Recruitment Status : Terminated (Slow accrual)
First Posted : June 14, 2007
Last Update Posted : September 24, 2015
Information provided by (Responsible Party):
National Cancer Centre, Singapore